Почетна › Неуробластом › Висконсин
Kliničke studije za Неуробластом u državi Висконсин
6 studija za Неуробластом traži učesnike na lokacijama u državi Висконсин.
Gradovi u državi Висконсин
Zvanični tekst studije (na engleskom)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Medical College of Wisconsin, Milwaukee
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- Children's Hospital of Wisconsin, Milwaukee
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- University of Wisconsin Carbone Cancer Center, Madison
Тражи се учесникФаза 1
7 Months – 21 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT02508038Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
- Midwest Children's Hospital, Milwaukee
Тражи се учесникФаза 1
12 Months – 20 Years · Оба пола · Ажурирано 8. 10. 2026. · NCT02013336Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- и још 1
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916SPEARHEAD-3 Pediatric Study
- University of Wisconsin Cancer Center, Madison
Тражи се учесникФаза 1/2
Узраст од 2 до 21 · Оба пола · Ажурирано 11. 8. 2026. · NCT05642455Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.